K. Osterkorn

Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany

Franz Heigl, R Hettich, Norbert Lotz et al. · Atherosclerosis Supplements · 2015 · 57 citations

Metabolic Syndrome, Thrombosis, Health Policy +9

Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients

Franz Heigl, R Hettich, Markus Suckfuell et al. · Atherosclerosis Supplements · 2009 · 31 citations

Pediatric Otolaryngology, Successful Second-line Treatment, Audiology +8

Effects of Days Open on Annualized Milk Yields in Current and Following Lactations

J.I. Weller, R. Bar-Anan, K. Osterkorn · Journal of Dairy Science · 1985 · 26 citations · Full text

Vergleichende Untersuchungen über die immunstimulierende (paramunisierende) Wirksamkeit von BCG, Levamisol,<i>Corynebacterium parvum</i>und Präparaten aus Pockenviren in verschiedenen<i>“in vivo”</i>‐und<i>“in vitro”</i>‐Testen

A. Mayr, M. Büttner, S. Pawlas et al. · Journal of Veterinary Medicine Series B · 1986 · 21 citations

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease

Franz Heigl, R Hettich, Norbert Lotz et al. · Clinical Research in Cardiology Supplements · 2015 · 18 citations · Full text

Progressive Cardiovascular Disease, Cardiometabolic Risk, Hyperlipidemia +20